REGENXBIO Inc.
RGNX· Nasdaq
RGNXREGENXBIO Inc.
Filed Mar 7, 2017 · 10-K · 66 days after period end · 0001564590-17-003576
| Metric | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|
| Revenue | $1.70M | $4.44M | $1.15M |
| Net Income | -$19.61M | -$5.18M | -$2.33M |
| EPS Diluted | -$0.74 | -$0.20 | -$0.97 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
REGENXBIO Inc. · CIK 1590877 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 7, 2017 · 66 d after period end
